DNA Biomed Solns (DNA) — Net Asset Quality Index
DNA Biomed Solns (DNA) has a Net Asset Quality Index of 98.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA100.00 Million minus total liabilities of ILA1.77 Million yields net assets of ILA98.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of DNA Biomed Solns to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
DNA Biomed Solns Net Asset Quality Index Over Time (2005–2024)
This chart shows how DNA Biomed Solns's Net Asset Quality Index has evolved across 19 annual periods from 2005 to 2024. As of June 2025, the index stands at 98.2%, representing net assets of ILA98.23 Million against total assets of ILA100.00 Million ILA. Explore cash efficiency ratio of DNA Biomed Solns to assess how effectively this company generates cash.
Annual Net Asset Quality Index for DNA Biomed Solns (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for DNA Biomed Solns from 2005 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DNA Biomed Solns stock valuation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | ILA101.47 Million | ILA104.28 Million | ILA2.81 Million | ▼ -0.9 pp |
| 2023 | 98.2% | ILA79.19 Million | ILA80.66 Million | ILA1.47 Million | ▲ +0.5 pp |
| 2022 | 97.7% | ILA80.11 Million | ILA81.99 Million | ILA1.88 Million | ▼ -1.8 pp |
| 2021 | 99.5% | ILA54.33 Million | ILA54.62 Million | ILA287.00K | ▲ +56.5 pp |
| 2020 | 43.0% | ILA7.95 Million | ILA18.49 Million | ILA10.54 Million | ▼ -33.7 pp |
| 2019 | 76.7% | ILA28.18 Million | ILA36.73 Million | ILA8.55 Million | ▼ -3.7 pp |
| 2018 | 80.4% | ILA64.90 Million | ILA80.72 Million | ILA15.81 Million | ▼ -8.1 pp |
| 2017 | 88.5% | ILA69.11 Million | ILA78.09 Million | ILA8.99 Million | ▲ +307.0 pp |
| 2016 | -218.5% | ILA-83.41 Million | ILA38.17 Million | ILA121.59 Million | ▼ -188.4 pp |
| 2015 | -30.1% | ILA-8.35 Million | ILA27.75 Million | ILA36.10 Million | ▲ +13.2 pp |
| 2014 | -43.3% | ILA-8.36 Million | ILA19.32 Million | ILA27.68 Million | ▼ -98.8 pp |
| 2013 | 55.6% | ILA11.49 Million | ILA20.68 Million | ILA9.19 Million | ▲ +1.2 pp |
| 2012 | 54.4% | ILA11.53 Million | ILA21.20 Million | ILA9.68 Million | ▼ -7.8 pp |
| 2011 | 62.1% | ILA10.45 Million | ILA16.82 Million | ILA6.37 Million | ▲ +56.1 pp |
| 2010 | 6.0% | ILA579.00K | ILA9.65 Million | ILA9.08 Million | ▲ +5398.6 pp |
| 2009 | -5392.6% | ILA-6.58 Million | ILA122.00K | ILA6.70 Million | ▼ -5333.5 pp |
| 2008 | -59.1% | ILA-3.00 Million | ILA5.07 Million | ILA8.07 Million | ▼ -0.8 pp |
| 2006 | -58.3% | ILA-1.99 Million | ILA3.42 Million | ILA5.41 Million | ▼ -108.6 pp |
| 2005 | 50.3% | ILA3.26 Million | ILA6.48 Million | ILA3.22 Million | — |